Clinical Trial Update: Moxonidine + Perindopril in Hypertensive Patients With Metabolic Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial update involving moxonidine and perindopril in patients with arterial hypertension and metabolic syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arterial Hypertension
• Metabolic Syndrome

Drugs mentioned

• Moxonidine (moxonidine)
• perindopril (perindopril)

Snippet

Sponsor: Sergey V. Nedogoda | Conditions: Arterial Hypertension, Metabolic Syndrome | Phase 4 | Status: UNKNOWN